David P Fairlie Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

9/2015	Nutrient and immune sensing are obligate pathways in metabolism, immunity, and disease.
1/2009	Histone deacetylase inhibitors in inflammatory disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David P Fairlie Research Topics

Disease

37	Neoplasms (Cancer) 05/2024 - 06/2004
27	Inflammation (Inflammations) 06/2023 - 01/2005
24	Infections 06/2023 - 02/2009
10	Malaria 01/2022 - 02/2006
7	Obesity 01/2017 - 02/2010
6	Bacterial Infections (Bacterial Infection) 01/2022 - 12/2015
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 11/2003
6	Colitis 01/2021 - 11/2003
6	Fibrosis (Cirrhosis) 10/2019 - 04/2010
6	Arthritis (Polyarthritis) 02/2016 - 09/2002
6	Edema (Dropsy) 07/2012 - 04/2002
6	Reperfusion Injury 01/2009 - 04/2002
5	Breast Neoplasms (Breast Cancer) 01/2018 - 07/2014
4	Pain (Aches) 01/2023 - 12/2010
4	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2014
4	Type 2 Diabetes Mellitus (MODY) 02/2017 - 05/2015
4	Ischemia 08/2007 - 04/2002
3	Colonic Neoplasms (Colon Cancer) 12/2023 - 01/2018
3	Melanoma (Melanoma, Malignant) 11/2020 - 12/2006
3	Metabolic Diseases (Metabolic Disease) 01/2016 - 01/2012
3	Bone Resorption 09/2015 - 07/2006
3	Body Weight (Weight, Body) 12/2013 - 05/2005
3	Stroke (Strokes) 06/2013 - 08/2007
3	Wounds and Injuries (Trauma) 06/2004 - 04/2002
2	Adenocarcinoma 12/2023 - 01/2018
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2023 - 04/2016
2	Tuberculosis (Tuberculoses) 01/2023 - 01/2019
2	Proteinuria 01/2021 - 01/2004
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2017
2	Thrombosis (Thrombus) 01/2021 - 01/2006
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 09/2012
2	Leukemia 11/2020 - 06/2015
2	Multiple Myeloma 11/2020 - 12/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019 - 01/2018
2	Necrosis 09/2019 - 05/2005
2	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2015
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2018 - 01/2018
2	Weight Loss (Weight Reduction) 01/2017 - 02/2012
2	Parasitemia 01/2017 - 02/2006
2	Experimental Arthritis 02/2016 - 07/2012
2	Disease Progression 02/2016 - 02/2012
2	Virus Diseases (Viral Diseases) 01/2016 - 11/2004
2	Communicable Diseases (Infectious Diseases) 01/2016 - 01/2012
2	Falciparum Malaria (Plasmodium falciparum Malaria) 12/2015 - 01/2012
2	Insulin Resistance 10/2015 - 12/2013

Drug/Important Bio-Agent (IBA)

19	Histone Deacetylase InhibitorsIBA 01/2022 - 06/2004
14	Histone Deacetylases (Histone Deacetylase)IBA 01/2023 - 12/2006
14	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2004
13	CytokinesIBA 06/2023 - 04/2010
12	Peptide Hydrolases (Proteases)FDA Link 05/2024 - 11/2004
12	PAR-2 ReceptorIBA 05/2024 - 10/2007
11	AntigensIBA 01/2023 - 09/2002
10	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2024 - 01/2006
10	Peptides (Polypeptides)IBA 01/2021 - 11/2004
10	Complement System Proteins (Complement)IBA 01/2018 - 04/2002
9	LigandsIBA 01/2023 - 01/2005
9	EnzymesIBA 01/2022 - 05/2005
9	Anaphylatoxin C5a ReceptorIBA 01/2017 - 04/2002
7	CollagenIBA 10/2019 - 06/2006
6	VaccinesIBA 12/2021 - 11/2006
6	Histones (Histone)IBA 12/2021 - 06/2004
6	Vorinostat FDA Link 01/2021 - 04/2010
5	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2023 - 12/2015
5	ChemokinesIBA 01/2023 - 09/2015
5	5- (2- oxopropylideneamino)- 6- d- ribitylaminouracilIBA 01/2021 - 11/2019
5	Peroxidase (Myeloperoxidase)IBA 02/2012 - 01/2003
4	Complement C5a (Complement 5a)IBA 01/2023 - 11/2011
4	Glucose (Dextrose)FDA LinkGeneric 07/2021 - 02/2013
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2009
4	CalciumIBA 01/2020 - 02/2012
4	CarbohydratesIBA 09/2015 - 09/2012
4	Antimalarials (Antimalarial Agents)IBA 07/2014 - 01/2012
4	Secretory Phospholipases A2IBA 07/2006 - 09/2003
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2004 - 04/2002
3	Antiviral Agents (Antivirals)IBA 12/2021 - 01/2016
3	TrypsinIBA 01/2021 - 02/2012
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 12/2013
3	Lysine (L-Lysine)FDA Link 01/2017 - 01/2012
3	AcPhe(ornithine- Pro- cyclohexylamine- Trp- Arg)IBA 01/2004 - 04/2002
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2003 - 04/2002
2	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2017
2	Bleomycin (Blenoxane)FDA LinkGeneric 10/2023 - 04/2016
2	Interleukin-17 (Interleukin 17)IBA 06/2023 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2019
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023 - 01/2018
2	Interleukin-23 (Interleukin 23)IBA 01/2022 - 11/2019
2	Granzymes (Granzyme)IBA 12/2021 - 01/2016
2	Proteinase-Activated ReceptorsIBA 01/2021 - 01/2006
2	PerforinIBA 01/2021 - 01/2018
2	AntibodiesIBA 01/2020 - 12/2019
2	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2017 - 01/2016
2	belinostatIBA 01/2017 - 12/2015
2	romidepsin (FK228)FDA Link 01/2017 - 12/2015
2	PanobinostatIBA 01/2017 - 12/2015
2	Interleukin-6 (Interleukin 6)IBA 02/2016 - 10/2015
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2016 - 05/2015
2	Insulin (Novolin)FDA Link 10/2015 - 02/2013

Therapy/Procedure

15	Therapeutics 05/2024 - 08/2007
3	Immunotherapy 12/2020 - 07/2014
2	Drug Therapy (Chemotherapy) 01/2017 - 06/2004